89Zr-DFO-Trastuzumab

trastuzumab (radiolabeled with zirconium-89 via DFO chelator) · Memorial Sloan Kettering Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 89Zr-DFO-Trastuzumab, covering 2024-12-10 to 2024-12-10. Get the full timeline:

Most recent: Clinical Trial Update: PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer [NA]